Cardiology · Heart Failure
The facts most likely to be tested
The most sensitive and specific physical exam finding for acute decompensated heart failure (ADHF) is an elevated jugular venous pressure (JVP).
Loop diuretics (e.g., furosemide) are the first-line therapy for patients with volume overload to achieve rapid symptomatic relief.
Intravenous vasodilators such as nitroglycerin are indicated in patients with ADHF who are hypertensive and have ongoing pulmonary edema.
Inotropes like dobutamine or milrinone are reserved for patients with ADHF presenting with cardiogenic shock or severe hypoperfusion.
B-type natriuretic peptide (BNP) levels are highly useful to distinguish dyspnea caused by heart failure from non-cardiac causes like COPD or pneumonia.
Non-invasive positive pressure ventilation (NIPPV), such as BiPAP, reduces the need for endotracheal intubation and improves mortality in patients with acute respiratory failure due to ADHF.
Beta-blockers should generally be continued in patients already on chronic therapy unless the patient is in cardiogenic shock or has severe bradycardia.
Vignette unlocked
A 72-year-old male with a history of HFrEF presents to the emergency department with progressive dyspnea and orthopnea over the last 3 days. Physical examination reveals bilateral crackles at the lung bases, a third heart sound (S3), and an estimated JVP of 14 cm H2O. His blood pressure is 165/95 mmHg and oxygen saturation is 88% on room air. A chest X-ray shows pulmonary vascular congestion and pleural effusions.
What is the most appropriate initial pharmacologic intervention to address this patient's acute symptoms?
Intravenous loop diuretics
The patient presents with classic signs of volume overload (elevated JVP, S3, pulmonary congestion), making intravenous loop diuretics the first-line treatment to reduce preload and improve symptoms as per the 'bets' regarding volume management.
Full handout
High yield triage
Etiology / Epidemiology
Common in elderly with HTN or CAD. Precipitated by medication non-compliance, ischemia, or arrhythmias.
Clinical Manifestations
Dyspnea, orthopnea, and paroxysmal nocturnal dyspnea. S3 gallop is the most specific physical exam finding.
Diagnosis
Echocardiogram is the gold standard. BNP > 400 pg/mL strongly supports the diagnosis of heart failure.
Treatment
IV Loop Diuretics (e.g., furosemide) are first-line. Avoid beta-blockers in acute decompensated states.
Prognosis
High 30-day readmission rate. Monitor daily weights and strict sodium restriction.
Full handout
Epidemiology & Etiology
ADHF is the leading cause of hospitalization in patients >65. Primary triggers include myocardial ischemia, uncontrolled hypertension, and dietary indiscretion. Iatrogenic causes include NSAIDs or non-dihydropyridine CCBs which exacerbate fluid retention.
Pertinent Anatomy
Left ventricular dysfunction leads to elevated left ventricular end-diastolic pressure (LVEDP). This pressure transmits retrograde into the pulmonary vasculature, causing pulmonary capillary wedge pressure elevation.
Pathophysiology
Increased filling pressures cause fluid extravasation into the alveoli, resulting in pulmonary edema. The body compensates via the RAAS and sympathetic nervous system, which paradoxically worsens afterload and fluid retention. This creates a vicious cycle of myocardial remodeling and worsening pump failure.
Clinical Manifestations
Patients present with rales, jugular venous distension, and peripheral edema. A displaced PMI suggests cardiomegaly. Hypotension with cold extremities indicates cardiogenic shock, a medical emergency requiring inotropic support.
Diagnosis
The Echocardiogram provides the left ventricular ejection fraction (LVEF). BNP > 400 pg/mL is highly sensitive, while BNP < 100 pg/mL effectively rules out heart failure. CXR may show Kerley B lines and cephalization of pulmonary vessels.
Treatment
Initial management follows the LMNOP mnemonic: Lasix, Morphine, Nitrates, Oxygen, and Position. IV Furosemide is the cornerstone for volume overload. Do not initiate or up-titrate beta-blockers during the acute phase as they decrease contractility. Use IV Nitroglycerin for rapid afterload reduction in hypertensive patients.
Prognosis
Patients face high mortality rates post-discharge. Daily weights are critical to detect early fluid accumulation. Long-term survival depends on achieving GDMT (Guideline-Directed Medical Therapy) once the patient is euvolemic.
Differential Diagnosis
COPD exacerbation: presence of wheezing and smoking history
Pulmonary Embolism: sudden onset pleuritic chest pain and tachycardia
Pneumonia: fever, productive cough, and focal consolidation
Acute Coronary Syndrome: ST-segment changes or elevated troponins
Renal Failure: elevated creatinine and uremic symptoms